$15.83

0.09 (0.57%)

2/9/2010 4:02 PM

WuXi PharmaTech (Cayman), Inc. (ADR) (WX)

CAPS Rating:

China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating WX

Add Stock to Watchlist

What the Community Thinks

Total Members

347 Outperforms

22 Underperforms

All-Stars

105 Outperforms

4 Underperforms

Wall Street

4 Outperforms

1 Underperforms

Members bullish on WX are also bullish on:

Members bearish on WX are also bearish on:

Ticker Tags

Aggressive Growth (860), Small Cap (1645), International Stock (684), IPO in 2007 (211), Growth (1902), Defensive (1457), Pharmaceuticals (149), Contract Research Services (7), Cayman Islands (2), China (251), Healthcare (711), Life Sciences Tools and Services (53)
Suggest a tag

WuXi PharmaTech (Cayman), Inc. (ADR) At A Glance

Current Price:	$15.83
Last Trade Time:	2/9/2010 4:02 PM
Open:	$0.00
Previous Close:	$15.74
Daily Range:	$15.32 - $15.99
52-Week Range:	$3.67 - $18.00
Volume:	397,584
Market Cap:	$1.08B
P/E Ratio:	10.51
Compare Our Special Broker Offers!

Stock Trends

WX VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for WX

Surprise Winners of the China/India Outsourcing War
2/4/2010 4:18:00 PM -
Wrangler West Announces Controller Appointment
1/25/2010 3:31:00 PM -
Beware Policy Risk, Look To The Web
1/25/2010 6:06:00 AM -
WuXi PharmaTech to Present at 28th Annual J.P. Morgan Healthcare Conference
1/6/2010 10:19:00 PM -

More Headlines...

Top Bull Pitch

Recs

1 WuXi PharmaTech (Cayman), Inc. (ADR) (WX)

Avatar Niksurfs (61.05) Submitted: 12/06/09 1:02 PM

WuXi PharmaTech is the leading China-based drug R&D outsourcing service company. Founded in December 2000 with the mission to transform the drug R&D industry and a vision to provide fully integrated drug R&D services to improve the success of research and shorten the time of development....More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1 WuXi PharmaTech (Cayman), Inc. (ADR) (WX)

Avatar iPicksEm (38.46) Submitted: 5/25/09 9:41 PM

CAPS put this in my inbox under weekly stock ideas. Well, I'm too lazy to do research so I'm going to go out on a limb and say under perform. I say under perform ONLY because I don't know the goals of this company.

*This is part of a new game I'll be playing with CAPS recommendation. For every sto...More

Replies: 1 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 45 : 1 2 3 4 5 Next »

Show Pitch Replies

Recs 1 (WX) Niksurfs (61.05) Submitted: 12/06/09 1:02 PM : Start Price: $5.26 WX Score: 174.95 WuXi PharmaTech is the leading China-based drug R&D outsourcing service company. Founded in December 2000 with the mission to transform the drug R&D industry and a vision to provide fully integrated drug R&D services to improve the success of research and shorten the time of development. If I said no more you should be thinking__hmm what are the largest cost drivers for Pharma. Scratching my chin, I would have to say___hmmm R&D, FDA, Phd's, and of course marketing. Congratulations....tell them what they've won Bob! R&D and PHd's are large drivers of cost, so is the development and testing as well as prep for mass prdtn of said compounds. Phd's in China work on average $.15-$.20 on the dollar compared to US counterparts (sometimes $.10) The Drug & Biotech companies can't shave costs from the FDA, nor Marketing like they can save major $ outsourcing research. Oila!! just like my ole alma mater semiconductors & sftwe, we have found another item to export_you guessed it. Nuf said "We provide pharmaceutical and biotechnology companies around the world with a full spectrum of drug R&D services. A key testament to the strength of our company is the quality of our customer base. We have worked with 90 customers so far in 2009, including nine of the top ten global pharmaceutical companies and we have experienced 100% repeat business from our top ten customers over the last three years." I own it and continue to accumulate_another no brainer.... Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (WX) 00100 (96.16) Submitted: 11/16/09 3:28 PM : Start Price: $14.97 WX Score: -9.04 Downthumb. Chinese biotech company. (outsourcing). Negative cash flow. Opaque financials. Low debt ratio. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (WX) jmt587 (99.83) Submitted: 9/28/09 3:00 PM : Start Price: $12.00 WX Score: 30.94 Chinese BioTech & Pharma Outsourcing company. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (WX) oxdeming (54.30) Submitted: 9/11/09 4:38 AM : Start Price: $11.55 WX Score: 34.44 China pharm is in the rising Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (WX) iPicksEm (38.46) Submitted: 5/25/09 9:41 PM : Start Price: $7.45 WX Score: -89.85 CAPS put this in my inbox under weekly stock ideas. Well, I'm too lazy to do research so I'm going to go out on a limb and say under perform. I say under perform ONLY because I don't know the goals of this company. *This is part of a new game I'll be playing with CAPS recommendation. For every stock selection they send, I will spend no more then ten minutes looking at it before deciding if it will over perform or under perform. Report this Post Replies: 1 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 45 : 1 2 3 4 5 Next »

Wall Street

Results 1 - 5 of 5

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackOppenheimer	81.36	05/28/09		NS	$8.54	+85.36%	+19.77%	+65.60
	TrackJimCramer	< 20	01/07/09		3W	$8.10	+95.43%	+20.34%	-75.10
	TrackPiperJaff	85.79	07/30/08		NS	$18.32	-13.59%	-12.91%	-0.68
	TrackSoros	82.58	09/30/07		NS	$28.20	-43.87%	-26.38%	-17.49

Results 1 - 5 of 5

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.